|
1
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: State of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang J, Shen L, Yang Q and Zhang C:
Overexpression of metadherin mediates metastasis of osteosarcoma by
regulating epithelial-mesenchymal transition. Cell Prolif.
47:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang N, Song WX, Luo J, Haydon RC and He
TC: Osteosarcoma development and stem cell differentiation. Clin
Orthop Relat Res. 466:2114–2130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qureshi A, Ahmad Z, Azam M and Idrees R:
Epidemiological data for common bone sarcomas. Asian Pac J Cancer
Prev. 11:393–395. 2010.PubMed/NCBI
|
|
6
|
Laschi M, Bernardini G, Geminiani M,
Ghezzi L, Amato L, Braconi D, Millucci L, Frediani B, Spreafico A,
Franchi A, et al: Establishment of four new human primary cell
cultures from chemo-naive italian osteosarcoma patients. J Cell
Physiol. 230:2718–2727. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong J, Liu Y, Liao W, Liu R, Shi P and
Wang L: miRNA-223 is a potential diagnostic and prognostic marker
for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang W and Luo YP: MicroRNAs in breast
cancer: Oncogene and tumor suppressors with clinical potential. J
Zhejiang Univ Sci B. 16:18–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu X and Li Z: The role of miRNAs in
cutaneous squamous cell carcinoma. J Cell Mol Med. 20:3–9. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y,
Liu C, Song W, Wang F, Zhang J, et al: DNA methylation
downregulated mir-10b acts as a tumor suppressor in gastric cancer.
Gastric Cancer. 18:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J
and Feng F: By downregulating TIAM1 expression, microRNA-329
suppresses gastric cancer invasion and growth. Oncotarget.
6:17559–17569. 2015.PubMed/NCBI
|
|
16
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong W, Li B, Wang J, Song Y, Zhang Z and
Fu C: MicroRNA-337 inhibits cell proliferation and invasion of
cervical cancer through directly targeting specificity protein 1.
Tumour Biol. 39:10104283177113232017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ueno K, Hirata H, Majid S, Yamamura S,
Shahryari V, Tabatabai ZL, Hinoda Y and Dahiya R: Tumor suppressor
microRNA-493 decreases cell motility and migration ability in human
bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer
Ther. 11:244–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu Y, Cheng Y, Song Y, Zhang Z, Deng M,
Wang C, Zheng G and He Z: MicroRNA-493 suppresses tumor growth,
invasion and metastasis of lung cancer by regulating E2F1. PLoS
One. 9:e1026022014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou W, Zhang C, Jiang H, Zhang Z, Xie L
and He X: miR-493 suppresses the proliferation and invasion of
gastric cancer cells by targeting RhoC. Iran J Basic Med Sci.
18:1027–1033. 2015.PubMed/NCBI
|
|
21
|
Okamoto K, Ishiguro T, Midorikawa Y, Ohata
H, Izumiya M, Tsuchiya N, Sato A, Sakai H and Nakagama H: miR-493
induction during carcinogenesis blocks metastatic settlement of
colon cancer cells in liver. EMBO J. 31:1752–1763. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tambe M, Pruikkonen S, Maki-Jouppila J,
Chen P, Elgaaen BV, Straume AH, Huhtinen K, Cárpen O, Lønning PE,
Davidson B, et al: Novel Mad2-targeting miR-493-3p controls mitotic
fidelity and cancer cells' sensitivity to paclitaxel. Oncotarget.
7:12267–12285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and kruppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li L, He S, Sun JM and Davie JR: Gene
regulation by Sp1 and Sp3. Biochem Cell Biol. 82:460–471. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mukhopadhyay D and Datta K: Multiple
regulatory pathways of vascular permeability factor/vascular
endothelial growth factor (VPF/VEGF) expression in tumors. Semin
Cancer Biol. 14:123–130. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun HB, Chen X, Ji H, Wu T, Lu HW, Zhang
Y, Li H and Li YM: miR494 is an independent prognostic factor and
promotes cell migration and invasion in colorectal cancer by
directly targeting PTEN. Int J Oncol. 45:2486–2494. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Zeng C, Tu M, Jiang W, Dai Z, Hu Y,
Deng Z and Xiao W: MicroRNA-200b acts as a tumor suppressor in
osteosarcoma via targeting ZEB1. Onco Targets Ther. 9:3101–3111.
2016.PubMed/NCBI
|
|
30
|
Yin Z, Ding H, He E, Chen J and Li M:
Up-regulation of microRNA-491-5p suppresses cell proliferation and
promotes apoptosis by targeting FOXP4 in human osteosarcoma. Cell
Prolif. 2016.
|
|
31
|
Song L, Yang J, Duan P, Xu J, Luo X, Luo
F, Zhang Z, Hou T, Liu B and Zhou Q: MicroRNA-24 inhibits
osteosarcoma cell proliferation both in vitro and in vivo by
targeting LPAATbeta. Arch Biochem Biophys. 535:128–135. 2013.
View Article : Google Scholar
|
|
32
|
Wu X, Zhong D, Gao Q, Zhai W, Ding Z and
Wu J: MicroRNA-34a inhibits human osteosarcoma proliferation by
downregulating ether a go-go 1 expression. Int J Med Sci.
10:676–682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dynan WS and Tjian R: The
promoter-specific transcription factor Sp1 binds to upstream
sequences in the SV40 early promoter. Cell. 35:79–87. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang WC and Hung JJ: Functional role of
post-translational modifications of Sp1 in tumorigenesis. J Biomed
Sci. 19:942012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Davie JR, He S, Li L, Sekhavat A, Espino
P, Drobic B, Dunn KL, Sun JM, Chen HY, Yu J, et al: Nuclear
organization and chromatin dynamics-Sp1, Sp3 and histone
deacetylases. Adv Enzyme Regul. 48:189–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pathi S, Jutooru I, Chadalapaka G, Nair V,
Lee SO and Safe S: Aspirin inhibits colon cancer cell and tumor
growth and downregulates specificity protein (Sp) transcription
factors. PLoS One. 7:e482082012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chintharlapalli S, Papineni S, Ramaiah SK
and Safe S: Betulinic acid inhibits prostate cancer growth through
inhibition of specificity protein transcription factors. Cancer
Res. 67:2816–2823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao Y, Chen H, Lin Y, Xu X, Hu Z, Zhu Y,
Wu J, Xu X, Zheng X and Xie L: microRNA-330 inhibits cell motility
by downregulating Sp1 in prostate cancer cells. Oncol Rep.
30:327–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Deacon K, Onion D, Kumari R, Watson SA and
Knox AJ: Elevated SP-1 transcription factor expression and activity
drives basal and hypoxia-induced vascular endothelial growth factor
(VEGF) expression in non-small cell lung cancer. J Biol Chem.
287:39967–39981. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang L, Wei D, Huang S, Peng Z, Le X, Wu
TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression
is a significant predictor of survival in human gastric cancer.
Clin Cancer Res. 9:6371–6380. 2003.PubMed/NCBI
|
